Genitourinary Cancers | Tumor

An Expert Highlights His Key Takeaways From The 2025 ASCO GU Symposium

February 28th 2025, 5:00pm

Video

Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.

There is a Growing Need For Genetic Testing and Precision Medicine in GU Cancers

February 28th 2025, 2:00pm

Article

Dr. Chandler Park helps patients with genitourinary cancers, including both prostate and bladder, understand the importance of genetic testing.

Personalized Medicine Makes Strides Across the GU Oncology Treatment Space

February 22nd 2025, 3:00pm

Video

Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

Navigating Time and Emotions After Testicular Cancer

February 19th 2025, 6:00pm

Article

I often reflect on my emotional changes following a testicular cancer diagnosis and how I learned to manage them and grow.

GAP Regimen May Not Improve Survival in Biliary Tract Cancer Subset

February 17th 2025, 2:00pm

Article

The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.

Patients With Prostate Cancer Experience Temporary Urinary Function Decline After CIRT

February 13th 2025, 10:00pm

Article

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to normal after three months.

An Expert Explains Updated Data For Patients With GU Cancers

February 13th 2025, 9:35pm

Video

Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at the 2025 ASCO GU meeting.

Talzenna Plus Xtandi May Improve Survival in mCRPC

February 13th 2025, 3:10pm

Article

Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower death risk with Talzenna plus Xtandi.

Diet Plus Fish Oil May Reduce Ki-67 Biomarkers in Prostate Cancer

January 16th 2025, 8:00pm

Article

A diet high in omega-3 fatty acids and low in omega-6 fatty acids, taken with fish oil, reduced the Ki-67 index in men with prostate cancer on active surveillance.

BLA Has Been Submitted For Kidney Cancer Imaging PET Product Zircaix

January 8th 2025, 2:00pm

Article

A Biologics License Application has been submitted to the FDA for treatment with the kidney cancer imaging PET drug product, Zircaix®.